about
Molecular imaging in drug developmentTargeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides.Clinical photoacoustic imaging of cancerCombining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.Ultrasound molecular imaging: Moving toward clinical translationQuantitative Assessment of Inflammation in a Porcine Acute Terminal Ileitis Model: US with a Molecularly Targeted Contrast Agent.Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.Ultrasound-guided delivery of microRNA loaded nanoparticles into cancerAssessment of Inflammation in an Acute on Chronic Model of Inflammatory Bowel Disease with Ultrasound Molecular ImagingQuantitative assessment of tumor angiogenesis using real-time motion-compensated contrast-enhanced ultrasound imaging.Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection.Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model.Multiparametric spectroscopic photoacoustic imaging of breast cancer development in a transgenic mouse model.Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical implications.Acoustic and photoacoustic molecular imaging of cancer.Molecular imaging: current status and emerging strategies.Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55).Molecular ultrasound imaging: current status and future directionsMolecular ultrasound assessment of tumor angiogenesisAntioxidants improve early survival of cardiomyoblasts after transplantation to the myocardium.Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivoPolymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy.Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes.A novel estrogen receptor intramolecular folding-based titratable transgene expression system.Imaging of VEGF receptor in a rat myocardial infarction model using PETIndirect imaging of cardiac-specific transgene expression using a bidirectional two-step transcriptional amplification strategy.PET imaging of tumor neovascularization in a transgenic mouse model with a novel 64Cu-DOTA-knottin peptide.CT perfusion of the liver: principles and applications in oncology.Quantification and monitoring of inflammation in murine inflammatory bowel disease with targeted contrast-enhanced US.Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice.Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancerBreast Cancer Detection by B7-H3-Targeted Ultrasound Molecular ImagingDevelopment of a High-Throughput Molecular Imaging-Based Orthotopic Hepatocellular Carcinoma ModelStromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinomaThree-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model.Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model.Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice.Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1.Noninvasive imaging of hypoxia-inducible factor-1α gene therapy for myocardial ischemia
P50
Q22122025-73992C7C-1AE8-4D24-88F7-0746BC8B6C14Q22255481-D50D3AD5-3F4F-436B-91CB-759614B6E809Q28078790-B6740D09-323F-427C-9AB5-0AB26BCB51B2Q30368922-EC5BDE6E-292A-4265-A411-BDBB5FB60DD6Q30375187-72F69E15-22B2-459A-B181-BFB80A062BBBQ30375481-953AE14F-8243-40B1-9BF0-999B7E1E2564Q30384642-6A08D0F7-00F5-45A1-B5C2-2BB897AE6F42Q30386140-063198AC-E03C-4CE5-8B95-4EF0FF7B985AQ30402938-789708FB-AB43-479E-89D7-0361946CE3BBQ30408880-A21FE551-C06C-406B-B2B6-E65D6ADE07CBQ30416185-2BD84BA1-A4C9-4892-87FD-1D6BD3CAD82FQ30417587-5A5F9097-CF40-4347-B9EB-FA7370FB5EACQ30429175-49C9993B-C14E-4307-B176-C0D3ABCFB2B7Q30429594-CD3B4917-5424-4897-809A-5550F3D71E7EQ30435305-4CF3C534-5917-41E8-9748-B71322C2903AQ30474579-2169EFAC-17EB-425D-8CFB-13A7684D6CA4Q30474689-EAFF511A-9437-428E-9234-AA3CB07B0814Q30474725-C31A7C25-1F51-4C6A-B1E6-21E149C96BCDQ30474770-BF0F3A96-7B88-470E-B500-EB47F9FF268EQ30475341-87D62F63-DB5E-4578-AA94-6FC4B268E9D0Q30484195-F04FDA2C-2D4C-45E0-814C-82752F16255EQ30632163-FC15D10D-78D4-428C-9FEF-573C66F77465Q33361745-93ED7A1D-7C55-40D7-8964-D3D0DCFFFCD5Q33713089-821D5D13-E2A3-4E9E-BBFC-824FA76F73C9Q33786497-304DB4F3-0EFE-453D-B152-6AA272A7BF76Q33977026-3B3DC6F4-3B88-4B21-80CD-1F155D810D56Q34677001-85259C80-64F8-4466-8F0B-A0D505D839E2Q34681040-463F8D58-BE9D-48D2-860A-4769DF134874Q35629916-4917AE6B-5681-4175-9709-BE140D47FEDBQ35655488-32A5A32A-89AF-426A-BC49-180D0399FCB6Q35729996-10A3BF15-651A-4856-8665-9CBC84192E8DQ35751840-BE7ADE74-E230-445E-A899-092530DD011BQ35827586-E5BC88AD-1DF3-4A7F-AE62-5F687B13B712Q36149299-B4203E3F-DED7-485D-9F0A-E699A9737B2CQ36232472-831757E5-BEF4-4809-952D-9A1AF641B4BBQ36699083-312C7FBC-7FC5-49E4-A2A5-8040C9368BADQ36871846-ED477A69-7229-4B73-893D-B8C2E221A425Q37133833-06381AD9-CF7D-4DD4-A8D4-93EED9F571DCQ37198592-82FC2181-9C68-4438-9CAB-081F7264B8FBQ37233533-6F3A01A3-4188-41F5-9D65-34B92AF6938A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Juergen K Willmann
@ast
Juergen K Willmann
@en
Juergen K Willmann
@es
Juergen K Willmann
@sl
type
label
Juergen K Willmann
@ast
Juergen K Willmann
@en
Juergen K Willmann
@es
Juergen K Willmann
@sl
prefLabel
Juergen K Willmann
@ast
Juergen K Willmann
@en
Juergen K Willmann
@es
Juergen K Willmann
@sl
P106
P21
P31
P496
0000-0003-4306-8171